Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

Brief Summary

Official Title: “Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey”

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

  • Study Type: Observational
  • Study Design: Observational Model: Cohort, Time Perspective: Prospective

Arms, Groups and Cohorts in this Clinical Trial

  • 1
    • Patients with bipolar disorder

Outcome Measures for this Clinical Trial

Primary Measures

  • Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
    • Safety Issue?: No

Secondary Measures

  • Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
    • Safety Issue?: No
  • Evaluation of co-morbid psychiatric diseases
    • Safety Issue?: No
  • Identification of treatment modalities selected according to the disease phase
    • Safety Issue?: No
  • Identification of the number of first degree relatives diagnosed with bipolar disorder
    • Safety Issue?: No
  • Evaluation of the relationship between patient and disease characteristics
    • Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • Patients previously or currently diagnosed with bipolar disorder
  • Patients (or any of their relatives) who give a written informed consent.

Exclusion Criteria

  • Patients who were previously included in this study.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: No

Clinical Trial Investigator Information

  • Lead Sponsor
    • AstraZeneca
  • Overall Official(s)
    • Mustafa Bilici, MD, Assoc. Prof, Study Director, Erenkoy State Hospital for Psychiatric Diseases, Istanbul, Turkey

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00660712